Amarin (United Kingdom)
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Amarin (United Kingdom), United Kingdom, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
32%
Total
Publications
178
Total Open
Publications
57
Total
Citations
1.9K
Open Access
Percentage
32%
Total
Publications
178
Total Open
Publications
57
Total
Citations
1.9K
Breakdown
Publisher Open
22%
Both
10%
Other Platform Open
1%
Closed
67%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
17
Hybrid 51%
30
No Guarantees 20%
12
Other Platform Open
Domain 62%
13
Other Internet 33%
7
Institution 24%
5
Public 5%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 13 |
DOI | Other Internet | 7 |
Royal Netherlands Academy of Arts and Sciences | Institution | 4 |
University of Milano-Bicocca | Institution | 1 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 1 |
Imperial College London | Institution | 1 |
Figshare | Public | 1 |
Europe PMC | Domain | 1 |